Recombinant vaccines of a CD4+ T-cell epitope promote efficient control of Paracoccidioides brasiliensis burden by restraining primary organ infection
Paracoccidioidomycosis (PCM) is an infectious disease endemic to South America, caused by the thermally dimorphic fungi Paracoccidioides. Currently, there is no effective human vaccine that can be used in prophylactic or therapeutic regimes. We tested the hypothesis that the immunogenicity of the im...
- Autores:
- Tipo de recurso:
- Fecha de publicación:
- 2017
- Institución:
- Universidad del Rosario
- Repositorio:
- Repositorio EdocUR - U. Rosario
- Idioma:
- eng
- OAI Identifier:
- oai:repository.urosario.edu.co:10336/18682
- Acceso en línea:
- https://doi.org/10.1371/journal.pntd.0005927
http://repository.urosario.edu.co/handle/10336/18682
- Palabra clave:
- Epítopo
Partícula similar a un virus
Interferón gamma
Hongos
Sintético
Linfocito T
Balb endogámico C
Paracoccidioides
Desarrollo y Envejecimiento
Vacuna
Interleucina 1
interleucina 12
interleucina 4
Vacuna recombinante
Factor de necrosis tumoral
Proteína de 43 Kda
Citocina
Epítopo
Proteína fúngica
Antígeno de hongos
Vacuna contra hongos
Glicoproteína
Vacuna recombinante
Vacuna contra partículas similares a virus
Célula animal
Experimento con animales
Modelo animal
Tejido animal
Linfocito T Cd4+
Inmunidad celular
Centrifugación
Quimera
Unidad de formación de Colonia
Estudio controlado
Replicación de ADN
Formulación de Medicamentos
Ensayo inmunoabsorbente ligado a enzimas
Hepatitis B
Histopatología
Humano
Célula humana
Inmunización
Inmunofenotipado
Inmunoprofilaxis
Proliferación de linfocitos
Método de estimación de la magnitud
Mortalidad
Síntesis de péptidos
Plásmido
Electroforesis en gel de poliacrilamida
Expresión de proteínas
Extracción de fase sólida
Blastomicosis sudamericana
Lesión de tejido
Microscopio de transmisión por electrones
Inmunogenicidad de la vacuna
Partícula de virus
Transferencia occidental
Ratón albino bagg
Genética
Crecimiento
Hepatitis B Virus
Memoria Inmunológica
Inmunología
Microbiología
Paracoccidioides
Paracoccidioidomicosis
Secreción (Proceso)
Célula Th1
Article
Th1 Cell
Secretion (Process)
Paracoccidioidomycosis
Microbiology
Liver
Immunology
Immunological Memory
Growth
Genetics
Western Blotting
Bagg Albino Mouse
Virus Particle
Vaccine Immunogenicity
Transmission Electron Microscopy
Tissue Injury
South American Blastomycosis
Solid Phase Extraction
Protein Expression
Polyacrylamide Gel Electrophoresis
Plasmid
Peptide Synthesis
Mortality
Magnitude Estimation Method
Lymphocyte Proliferation
Immunoprophylaxis
Immunophenotyping
Immunization
Human Cell
Human
Histopathology
Enzyme Linked Immunosorbent Assay
Drug Formulation
Dna Replication
Controlled Study
Colony Forming Unit
Chimera
Centrifugation
Cellular Immunity
Cd4+ T Lymphocyte
Animal Tissue
Animal Model
Animal Experiment
Animal Cell
Virus Like Particle Vaccine
Recombinant Vaccine
Glycoprotein
Fungus Vaccine
Fungus Antigen
Fungal Protein
Epitope
Cytokine
43 Kda Protein
Tumor Necrosis Factor
Recombinant Vaccine
Interleukin 4
Interleukin 12
Interleukin 1
Vaccine
Development And Aging
Paracoccidioides
Inbred Balb C
T-Lymphocyte
Synthetic
Fungal
Gamma Interferon
Virus-Like Particle
Epitope
Glucoproteinas
Paracoccidioidomycosis
Micosis
- Rights
- License
- Abierto (Texto Completo)
Summary: | Paracoccidioidomycosis (PCM) is an infectious disease endemic to South America, caused by the thermally dimorphic fungi Paracoccidioides. Currently, there is no effective human vaccine that can be used in prophylactic or therapeutic regimes. We tested the hypothesis that the immunogenicity of the immunodominant CD4+T-cell epitope (P10) of Paracoccidioides brasiliensis gp43 antigen might be significantly enhanced by using a hepatitis B virus-derived particle (VLP) as an antigen carrier. This chimera was administered to mice as a (His)6-purified protein (rPbT) or a replication-deficient human type 5 adenoviral vector (rAdPbT) in an immunoprophylaxis assay. The highly virulent Pb18 yeast strain was used to challenge our vaccine candidates. Fungal challenge evoked robust P10-specific memory CD4+T cells secreting protective Th-1 cytokines in most groups of immunized mice. Furthermore, the highest level of fungal burden control was achieved when rAdPbT was inoculated in a homologous prime-boost regimen, with 10-fold less CFU recovering than in non-vaccinated mice. Systemic Pb18 spreading was only prevented when rAdPbT was previously inoculated. In summary, we present here VLP/P10 formulations as vaccine candidates against PCM, some of which have demonstrated for the first time their ability to prevent progression of this pernicious fungal disease, which represents a significant social burden in developing countries. © 2017 Holanda et al. |
---|